Identification of Protein Components in Human Acquired Enamel Pellicle and Whole Saliva Using Novel Proteomics Approaches*

Yuan YaoDagger §, Eric A. Berg§||, Catherine E. Costello||, Robert F. TroxlerDagger ||, and Frank G. OppenheimDagger ||**

From the Dagger  Department of Periodontology and Oral Biology, Boston University School of Dental Medicine and the  Mass Spectrometry Resource and || Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118

Received for publication, June 25, 2002, and in revised form, October 21, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Precursor proteins of the acquired enamel pellicle derive from glandular and non-glandular secretions, which are components of whole saliva. The purpose of this investigation was to gain further insights into the characteristics of proteins in whole saliva and in vivo formed pellicle components. To maximize separation and resolution using only micro-amounts of protein, a two-dimensional gel electrophoresis system was employed. Protein samples from parotid secretion, submandibular/sublingual secretion, whole saliva, and pellicle were subjected to isoelectric focusing followed by SDS-PAGE. Selected protein spots were excised, subjected to "in-gel" trypsin digestion, and examined by mass spectrometry (MS). The data generated, including peptide maps and tandem MS spectra, were analyzed using protein data base searches. Components identified in whole saliva include cystatins (SA-III, SA, and SN), statherin, albumin, amylase, and calgranulin A. Components identified in pellicle included histatins, lysozyme, statherin, cytokeratins, and calgranulin B. The results showed that whole saliva and pellicle have more complex protein patterns than those of glandular secretions. There are some similarities and also distinct differences between the patterns of proteins present in whole saliva and pellicle. MS approaches allowed identification of not only well characterized salivary proteins but also novel proteins not previously identified in pellicle.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human teeth are exposed to whole saliva (WS),1 consisting mainly of secretions derived from three pairs of major salivary glands, which comprise parotid, submandibular, and sublingual glands. Protein components that have been identified in all of the major glandular secretions are proline-rich proteins (acidic, basic, and glycosylated families), amylase, statherin, histatins, lysozyme, lactoferrin, lactoperoxidase, and secretory IgA (1-10), whereas cystatins and mucins have been identified in submandibular/sublingual secretions (9, 11-13). However, detailed understanding of the protein composition in WS is still limited because of the lack of knowledge about proteins in other contributors to whole saliva such as secretions from minor salivary glands and gingival crevicular fluid. In addition, little is known about modifications that occur on proteins during or after secretion into the oral cavity.

The acquired enamel pellicle (EP) is a protein film thought to result from the selective adsorption of precursor proteins present in WS onto tooth surfaces. Because of its intimate contact with enamel surfaces, the EP plays an important role in maintaining tooth integrity by controlling the mineral solution dynamics of enamel. At its interface with the oral environment, the EP exerts selectivity on bacterial attachment and is involved in the initial stages of plaque formation (14). Because of the limiting amount of proteins that can be harvested from EP formed in vivo, previous investigations have utilized sensitive but indirect approaches such as enzymatic assays and immunologic detection to identify EP components (15-19).

One of the ways for direct identification of EP components is mass spectrometry (MS). MS has undergone considerable advances in the sensitive and specific analysis of biological materials (20). The development of matrix-assisted laser desorption/ionization (MALDI) MS by Hillenkamp and colleagues (21, 22) greatly increased the ability to analyze non-volatile biomolecules. Since then, improvements in MALDI-time-of-flight (MALDI-TOF) mass spectrometers and sample handling methodologies have allowed very high throughput, primarily as a result of the speed of data acquisition and greater tolerance of contaminants (e.g. salts and detergents) by MALDI when compared with other MS methods (23). The introduction of quadrupole orthogonal time-of-flight (QoTOF) MS has provided yet another level of sophisticated analysis (24, 25). The coupling of quadrupoles to the TOF analyzer initially generated electrospray ionization (ESI) data with high sensitivity (<10 fmol) and mass accuracy (<20 ppm) and allowed for tandem experiments that give much more complete and reliable data to facilitate protein identification and characterization (26). The more recent addition of a MALDI source to the QoTOF mass spectrometer gave these instruments additional flexibility (27). These advances in MS have been employed in a variety of biological investigations including cataloguing bacterial proteomes (28, 29), identifying differences in protein expression in disease versus normal cells (30, 31), and characterizing post-translational modifications of specific proteins (32, 33).

Recently, our group carried out the first direct identification of proteins found in EP formed in vivo using a MS approach with samples separated on one-dimensional SDS gels (34). We have now addressed complications that arise from the presence of multiple components in an apparent single electrophoretic band by achieving better resolution of the protein mixture through the use of two-dimensional electrophoresis (2-DE). Application of 2-DE has only been reported in a few investigations on proteins in WS (35-37), and none so far on proteins found in in vivo formed EP. In none of these EP studies were proteins identified using MS techniques. In the present study, we used 2-DE to resolve and compare proteins from glandular secretions, WS, and EP and identified selected components from WS and EP using mass spectrometry.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human Subjects-- Healthy non-medicated male and female volunteers, ranging in age from 20 to 60 years, were selected. The subjects exhibited no overt signs of gingivitis or caries. Saliva and pellicle collection protocols were approved by the Institutional Review Board of Boston University Medical Center, and informed consent was obtained from each subject.

Collections of Glandular Secretions and WS-- Parotid secretion (PS) from both glands was collected by means of a Carlson-Crittenden device (38). Submandibular/sublingual secretion (SMSL) was collected using a custom-fitted device consisting of a plastic core covered with Impregum F Impression material (3M ESPE, Seefeld, Germany). The flow of glandular secretion was provoked by gustatory stimulation using sugar-free lemon-flavored candies. Collection of WS was carried out under masticatory stimulation using a uniform bolus of ParafilmTM (Fisher Scientific, Pittsburgh, PA). The samples were kept on ice during the collection procedure. Immediately after the collection, WS samples were centrifuged at 14,000 × g for 20 min in a microcentrifuge at 4 °C to remove undissolved materials. Samples of glandular secretions and WS supernatant collected from two subjects were pooled and stored in 200-µl aliquots at -20 °C. Protein concentrations were determined using a micro-BCA protein assay (Pierce).

Harvesting of Human EP-- The collection procedure for the in vivo EP was carried out as described (34). Briefly, each donor was subjected to a thorough dental prophylaxis employing a coarse pumice containing no additives. EP was then allowed to form on the enamel surfaces over a 2-h period. Teeth in each quadrant were isolated with cotton rolls, rinsed twice with water, and dried with air. A Durapore PVDF membrane (Millipore, Bedford, MA) soaked in 0.5 M sodium bicarbonate buffer, pH 9.0, was held with a pair of cotton pliers and used to swab the coronal two thirds of the labial/buccal surfaces spanning from the central incisor to the first molar. One PVDF membrane was used for the collection of pellicle in each quadrant. The resulting four membranes from one subject were placed into a polypropylene microcentrifuge tube. To recover pellicle proteins from PVDF membranes, 1 ml of distilled water was added to each tube and extraction of pellicle was carried out by vortexing the sample for 30 s followed by sonication (Branson Cleaning Equipment Co., Shelton, CT) for 5 min in an ice bath at 4 °C. Control experiments using two-dimensional electrophoresis (2-DE) showed that sonication of PS under these conditions provoked undetectable fragmentation of proteins/peptides. To separate the extraction liquid from the membrane, a small needle-size (16-gauge) hole was placed on the bottom of the tube followed by centrifugation in a microcentrifuge and the pellicle extract was collected into a separate tube. Pellicle samples were then desalted using sequential dilution-centrifugation steps in an Amicon microcentrifuge device (Millipore) with a molecular mass cut-off of 3000 Da. Desalted pellicle samples were then analyzed using a micro-BCA protein assay to determine protein concentration.

Two-dimensional Gel Electrophoresis-- 2-DE (28, 39, 40) was carried out by isoelectric focusing (IEF) using pre-made immobilized pH gradient (IPG) strips on the Protean IEF cell (Bio-Rad) followed by SDS-PAGE using the Protean-II device (Bio-Rad). Approximately 50 µl of PS, SMSL, WS, or pooled EP samples containing 100 µg of proteins was mixed with 300 µl of IEF rehydration buffer in a focusing tray upon which a 17-cm-long, pre-made IPG strip was added. Rehydration was carried out in the tray under a constant voltage of 50 V for 12 h. The voltage was then gradually increased to 10,000 V, and samples were focused for an additional 6 h. To prepare the IPG strip for the second dimension, the strip was first equilibrated in a buffer containing 50 mM Tris-HCl, pH 8.8, 30% glycerol, 2% SDS, 6 M urea with 1% dithiothreitol (Sigma) for 10 min at room temperature, followed by a second equilibration for 10 min using the same buffer except that dithiothreitol was replaced by 4% iodoacetamide (Sigma). Subsequently, the IPG strip was applied horizontally on top of a 10% SDS-polyacrylamide gel (20 × 20 cm), and proteins/peptides were separated vertically for 16 h at a constant voltage of 105 V. The resulting two-dimensional gel was stained either with silver (Owl Separation System, Portsmouth, NH) or with Sypro-Ruby (Molecular Probes, Eugene, OR). Gels with the Sypro-Ruby staining were visualized under ultraviolet light using a Gel-Doc 1000 Imager (Bio-Rad).

Mass Spectrometry-- Protein spots were excised from two-dimensional gels using a sterile, cut pipette tip. Proteins contained in the gel were digested with sequencing-grade trypsin (Promega, Madison, WI) as previously described (41). Tryptic peptides were extracted from gel pieces with 1% trifluoroacetic acid in 50% acetonitrile and dried using a Speed-VacTM (Thermo Savant, Holbrook, NY). The resulting samples were resuspended in 0.1% trifluoroacetic acid and desalted using ZiptipsC-18TM (Millipore) as per the instructions from the manufacturer. Samples were then dried and resuspended in 50% methanol with 1% formic acid and were analyzed using both the Finnigan MAT Vision 2000 MALDI-TOF reflectron mass spectrometer (Thermo Finnigan, San Jose, CA) equipped with an ultraviolet laser (nitrogen, 337 nm) and the Applied Biosystems/MDS-Sciex QStar Pulsari quadrupole/orthogonal acceleration TOF mass spectrometer (QoTOF) with nanospray and MALDI (UV laser; nitrogen, 337 nm) sources (Applied Biosystems Inc., Framingham, MA). The MALDI-TOF MS was used initially to both screen samples to ensure adequate digestion and peptide recovery and to analyze samples at higher mass ranges. The QoTOF was then used to obtain data with high mass accuracy as well as to obtain tandem MS data. The MALDI matrix was 2,5-dihydroxybenzoic acid (DHB), and typically 50-200 laser shots were summed for each spectrum. The laser power used was between 50 and 60% when obtaining the Vision spectra and 30-33 µJ when obtaining the QoTOF spectra. When obtaining QoTOF nanospray data, 1-µm nanospray tips, pulled with a Sutter model P-87 micropipette puller, were used with an ion source voltage of 1000-1300 V. For tandem data, nitrogen was used as the collision gas and a range of operator-controlled collision voltages (12-50 V for electrospray; 35-90 V for MALDI) were employed. Spectra were analyzed systematically by manually reconstructing mass data with tabulation of peaks having an area of 1.0% or greater relative to the largest peak. Peaks corresponding to trypsin autolysis peptides were not included. Mass lists were used to screen against tryptic fragment libraries including Mascot (Matrix Sciences Ltd.; www.matrixscience.com), PROWL (Rockefeller University and New York Universities; www.prowl.rockefeller.com), Protein Prospector (University of California at San Francisco; www.prospector.ucsf.edu), PepSea (Protana; 195.41.108.38) and PeptideSearch (EMBL; www.mann.embl-heidelberg.de) to identify salivary and pellicle components. Instruments were externally calibrated, and identification of fragment mass matches used an error of 0.1% for data obtained using the Vision 2000 MALDI-TOF MS and 50 ppm for data obtained using the QoTOF. In samples with appropriate signal (>10 counts), tandem MS data was obtained with the QoTOF and resultant fragmentation data were screened using the PepSea and Mascot data bases. The validity of protein matches was confirmed by either additional tandem data or a careful examination of all MS data available for that particular sample, and total coverage for each result was calculated.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

EP formed in vivo from a pooled sample derived from 20 subjects (100 µg) showed a characteristic 2-DE pattern using a focusing range of pH 3-10 (Fig. 1, panel A). Visual inspection of the gel revealed that most of the proteins/peptides were distributed into three zones dictated by molecular mass. The high molecular mass region I, spanning between 36 and 97 kDa, contained many detectable spots clustered together, which primarily focused between pI 5 and 6. The middle molecular mass region II, ranging between 21 and 36 kDa, again showed clustering of many spots focused between pI 5 and 7. The low molecular mass region III, covering the area below 21 kDa, contained many spots focusing in the range of pI 4-8. It is interesting to note that pI ranges for the major spots in the three zones expand as their molecular masses decrease. A 2-DE gel of proteins from a WS pool prepared using the same electrophoretic conditions revealed a different pattern from that of EP (Fig. 1, panel B). Although proteins were also mainly distributed into zones I-III in the vertical dimension, they were focused horizontally into wider pI ranges in zone I and II with major spots shifted to a more basic pI region than was observed with EP. To our knowledge, this is the first time that well resolved EP and WS samples are shown in 2-DE gels with a full view (pI range 3-10 and molecular mass range 0-200 kDa). However, the relatively similar pI values among some components in both biological samples clearly pointed to the necessity of further resolving these proteins/peptides. Because most of the major components were contained in the pI 5-8 range, narrow range IPG strips (pH 5-8) were subsequently applied in the IEF phase of the 2-DE.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1.   Two-dimensional gel electrophoresis using isoelectric focusing with pH range 3-10 in the horizontal dimension and SDS-PAGE (10%) in the vertical dimension. Panel A, 100 µg of EP, stained with Sypro-Ruby and shown in inverted form for better contrast. Panel B, 100 µg of WS, stained with silver. Gel spots that were cut out for in-gel trypsin digestion and analyzed by MS were labeled P1-P13 and S1-S3 (P denotes EP, and S denotes WS). Horizontal lines divide the gels into zones I, II, and III, representing high, middle, and low molecular mass regions, respectively.

The pattern of spots visualized by 2-DE of proteins in WS and EP (Fig. 1) was next compared with those in PS and SMSL because the latter secretions are thought to contain primarily intact proteins which can serve as precursors to those in WS and the EP. The electrophoretogram of protein (100 µg) from pooled PS showed a profile of proteins with well defined separation (Fig. 2, panel A). Using the same zoning criteria, zone I contained ~30 detectable spots, which largely focused between pI 6 and 7. Zone II consisted of at least 10 distinguishable spots, which were focused between pI 5 and 6. Zone III was divided mainly into two regions. The acidic region contained 3 heavily stained spots between pI 5 and 5.5 and several spots that migrated below pI 5. The basic region (pI higher than 7) contained ~12 spots that were clearly discernible. A similar, but not identical, electrophoretic pattern was observed with SMSL (Fig. 2, panel B). The differences are likely caused by the presence of some proteins in SMSL such as mucins and cystatins, which are absent in PS. The tailing effect in the region above zone I (Fig. 2, panel B) may be caused by migration of MUC-7 glycoforms (42). Additional spots seen in the basic region of zone III (Fig. 2, panel B) likely represent cystatin molecules. Although the data in Fig. 2 were obtained using pooled samples from two subjects, very similar electrophoretic patterns were obtained with samples from several other subjects.


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 2.   Two-dimensional gel electrophoresis of salivary glandular secretions by isoelectric focusing with pH range 5-8 in the horizontal dimension and SDS-PAGE (10%) in the vertical dimension. Panel A, proteins from PS (100 µg); panel B, proteins from SMSL (100 µg). Both gels were stained with Sypro-Ruby. Zones I, II, and III correspond to high, middle, and low molecular mass regions, respectively. *, zone I 5-protein spot series.

Given the relatively simple electrophoretograms from both PS and SMSL, one may imagine that WS, representing mostly a mixture of glandular secretions with only minor contributions from gingival crevicular fluid, would show an electrophoretic pattern that would nearly be a summation of the two protein patterns (Fig. 2, A and B). Therefore, it was surprising to find that there were significant differences between the protein patterns observed for glandular secretions (Fig. 2, A and B) and WS (Fig. 3) in the pI range 5-8. First, the number of detectable protein spots in WS was dramatically greater than those in either PS (Fig. 2A) or SMSL (Fig. 2B). There were approximately 65 spots in zone I, 43 spots in zone II, and 30 in zone III. Second, proteins/peptides in WS seemed to be more distributed evenly throughout the pH range 5-8, in contrast to the clustering of spots in specific pH ranges that was observed in glandular secretions. Some proteins in glandular secretions such as the 5-protein spot series in the 40-45-kDa region (zone I, indicated by * in Fig. 2, A and B) were absent in WS, whereas more proteins/peptides were detectable in zone II of WS. These observations lend support to the finding that WS represents a mixture of proteins not only derived from different sources but, more importantly, proteins that have undergone significant processing and modification upon entering the oral cavity.


View larger version (95K):
[in this window]
[in a new window]
 
Fig. 3.   Two-dimensional gel electrophoresis of WS (100 µg) by isoelectric focusing with pH range 5-8 in the horizontal dimension and SDS-PAGE (10%) in the vertical dimension. The gel was stained with Sypro-Ruby. Gel spots that were cut out for in-gel trypsin digestion and analyzed by MS were labeled S4-S17. Zones I, II, and III indicate high, middle, and low molecular mass regions, respectively. Framed area contains eight protein doublets representing amylase isoforms.

EP was also analyzed using the narrow focusing range pH 5-8 (Fig. 4). A more refined pattern of spots was observed when EP was separated by this range in comparison to that shown in Fig. 1. This is particularly pronounced in the high (zone I) and middle (zone II) molecular mass zones because of greater resolution of the proteins/peptides separated in a narrower pH range exhibiting very close pI values. When components had greater pI variance, adequate separation could be obtained in both pH ranges as seen in zone III of Figs. 1 and 4. More than 40 spots were observed in each of the three zones, showing an overall distribution pattern that was essentially the same as that observed with the broad pH range gels (Fig. 1). The majority of the spots in zone I (Fig. 4) were focused between pI values of 5 and 6. This range expanded to pI 5-7 for zone II and to 5-8 for zone III. Spots with high staining intensity appeared in the same location for both gels and represent proteins/peptides of relatively high abundance. Despite of the fact that the EP analyzed over the pH range 3-10 was derived from a pool of pellicle proteins obtained from different subjects than the EP analyzed over pH range 5-8, there are considerable similarities in the overall EP patterns. These similarities point toward a consistency in EP composition and suggest that the generation of its constituents is dictated by a common mechanism.


View larger version (89K):
[in this window]
[in a new window]
 
Fig. 4.   Two-dimensional gel electrophoresis of EP (100 µg) by isoelectric focusing with pH range 5-8 in the horizontal dimension and SDS-PAGE (10%) in the vertical dimension. The gel was stained with Sypro-Ruby. Gel spots that were cut out for in-gel trypsin digestion and analyzed by MS were labeled P14-P23. Zones I, II, and III indicate high, middle, and low molecular mass regions, respectively.

The difference between the electrophoretic patterns of EP and WS (Fig. 1, panels A and B) became more obvious when these proteins were separated in the focusing range of pH 5-8 (Figs. 3 and 4). In zone I, few of the spots observed in the pI range of 5-6 in EP were observed in WS, whereas the staining intensity for the protein series between pI 6 and 7 was significantly reduced in EP compared with WS. In zone II, very few of the spots observed in EP seemed to relate to those in WS. Although a few EP proteins in zone III were comparable with those in WS with respect to spot location, they varied in staining intensity. To identify specific protein/peptide components in EP and WS, MS methods were employed. Selected protein spots from WS and EP 2-DE gels were subjected to in-gel trypsin digestion (43) and analyzed using a MALDI-TOF and ESI- and MALDI-QoTOF mass spectrometers. Data were acquired with several types of mass spectrometers to ensure more complete coverage of identified spots. Analyzed protein spots are labeled numerically in Figs. 1, 3, and 4 (S for WS and P for EP). Results for individual proteins identified are summarized in Table I. In general, the experimentally observed pI values were in good agreement with values reported in protein data bases. Exceptions are lysozyme, histatin 3, and calgranulin B. The discrepancy could be related in part to covalent modifications occurring during the EP formation and in part to steric influences and structural/conformational contributions. Details with respect to matching peptide masses as well as observed modifications (oxidation, pyroglutamination, phosphorylation, and alkylation) for each protein are given in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Assignment of gel components from whole saliva and in vivo pellicle

                              
View this table:
[in this window]
[in a new window]
 
Table II
Summary of MS data used for protein assignment
Superscript CAM indicates that the peptide contains carboxyamidomethylation of a cysteine residue. Superscript O indicates that the peptide contains an oxidized methionine residue. Superscript q indicates that the peptide contains a pyroglutamine. Superscript P indicates that the peptide contains a phosphorylated residue. Asterisk denotes the tryptic fragments from which tandem MS data were obtained.

Proteins identified in WS include cystatin SA, cystatin SA-III, statherin, cystatin SN, calgranulin, salivary amylase, and serum albumin. Fig. 5 contains representative MALDI-QoTOF MS (panel A) and MS/MS (panel B) spectra from spot S4. The MALDI-QoTOF MS spectrum (Fig. 5A) contains several major ions at m/z 842.48, 1292.67, 1897.90, 1914.95, 2109.98, and 2270.05. Some of these peaks correspond to trypsin autolysis products (e.g. m/z 842.48). Peptide ion masses not coincident with trypsin autolysis products were selected for collision-induced dissociation (CID) tandem MS experiments.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   MS analysis of tryptic peptides from spot S4. Panel A, MALDI-QoTOF mass spectrum. Peaks matching cystatin SN tryptic fragments are labeled with their N- and C-terminal amino acid residue number in parentheses. Inset shows pyroglutamination ([M + H]+; m/z 1897.90) of the peptide corresponding to residues 47-63 ([M + H]+; m/z 1914.95) with a loss of 17 daltons (amine group). Panel B, MALDI-QoTOF tandem MS spectrum of tryptic peptide [M + H]+; m/z 1292.67 corresponding to residues 19-29 of cystatin SN. This confirmed the identification of S4 as cystatin SN. Superscript q indicates pyroglutamination. Spectra were accumulated for 30-60 s; MALDI matrix was DHB; laser power, 50 µJ.

Fragmentation of ions by CID has been shown to occur primarily at and around the peptide bond (44). Scheme 1 is a diagram of the designations for peptide fragments from a theoretical peptide (45, 46). The most common fragments observed using low energy CID are b ions (containing the N-terminal amino acid) and y (containing the C-terminal amino acid). The other ions (a, c, x, and z) are also observed in low energy CID experiments but appear less frequently. Single amino acids are also observed in tandem experiments in the form of immonium ions.


View larger version (18K):
[in this window]
[in a new window]
 
Scheme 1.   Designations for fragment ions from a peptide (44, 45).

An example of such a CID tandem MS experiment is shown in Fig. 5B, where the parent ion with m/z 1292.67 (Fig. 5A) was subjected to a range of collision voltages (50-110 V) resulting in multiple fragment ions as well as the parent ion 1292.65 (Fig. 5B). Because all ions in the MALDI MS spectrum (Fig. 5A) are singly charged (M + H)+, more energy is required for fragmentation than is needed for multiply charged ions generated by ESI (see below). It is also harder to control fragmentation, as evident by the large number of low mass ions, internal ions (loss of both N- and C-terminal amino acids), and immonium ions. Data base searching (PepSea) using the fragmentation data obtained from these experiments matched to the protein, cystatin SN. Fragment ions from the tandem MS spectrum (Fig. 5B) are labeled reflecting nearly complete b and y ion series. Additionally, a, c, x, z, and immonium ions were also detected, as well as many amine and water losses. Reexamination of the MS spectrum (Fig. 5A) yielded other matching peptides confirming the protein identification with 81% sequence coverage. Several tryptic peptides that do not appear to match with theoretical digestion products for cystatin SN (e.g. m/z 1897.90) can be assigned by noting their relationship to the series of peptides with N-terminal glutamine that is observed at higher mass of 17.05 daltons (Fig. 5A, see inset). The difference of 17 daltons (NH3) is consistent with the formation of pyroglutamine and has been previously reported as a side reaction during in-gel digestion (47).

Table I also lists the proteins identified from 2-DE gels of EP. These proteins include lysozyme, histatin 3, histatin 1, statherin, cytokeratins, calgranulin B, and phosphodiesterase. The corresponding gel and spot number as well as relevant electrophoresis data (apparent pI and molecular mass) are also listed. Not surprisingly, the samples analyzed from the narrow range gels tended to contain less mixed protein spectra that the broad range gels. Quality results were, however, still obtained from the broad range gels. For example, Fig. 6 shows representative ESI-QoTOF MS (panel A) and ESI-QoTOF MS/MS (panel B) spectra from P12 (shown in Fig. 1). Resultant data base searches allowed for the identification of this protein as cytokeratin 15, an oral epithelial specific type I keratin. Although a number of ions corresponding to cytokeratin 15 are detectable, there are many peaks present that do not correspond to this protein, indicating that an unidentified protein is also present in the spectrum.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 6.   MS analysis of tryptic peptides from spot P12. Panel A, ESI-QoTOF mass spectrum. Peaks matching cytokeratin 15 tryptic fragments are labeled with the charge state as well as their N- and C-terminal amino acid residue number in parentheses. Panel B, ESI-QoTOF tandem MS spectrum of the tryptic peptide ([M + 2H]2+; m/z 651.35) corresponding to residues 125-136 of cytokeratin 15. This confirmed the identification of P12 as cytokeratin 15. Spectra were accumulated for 30-60 s.

Fig. 7 contains representative MALDI-TOF MS (panel A), ESI-QoTOF MS (panel B), and ESI-QoTOF MS/MS (panel C) spectra from P17. The data from the MALDI-TOF MS (Fig. 7A) and the ESI-QoTOF MS (Fig. 7B) are comparable, with the exception that ions are detected at higher m/z values in the MALDI-TOF mass spectrum. This is a result of the difference between MALDI ionization, which produces singly charged species (z = 1), as compared with a nano- or electrospray source, which produces primarily multiply charged ions (z > 1). Additionally, the use of different ionization methods yielded different distributions of peptide ions with some only present in the MALDI spectrum (e.g. m/z 3180.3), whereas other species are only visible in the ESI spectrum. These may represent peptides for which analysis reveals the presence of additional components in the mixture, the signals of which are suppressed in the MALDI or nano-ESI mass spectrum.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 7.   MS analysis of tryptic peptides from spot P17. Panel A, MALDI-TOF spectrum. Panel B, ESI-QoTOF mass spectrum. Peaks matching calgranulin B tryptic fragments are labeled with the charge state, as well as their N- and C-terminal amino acid residue number in parentheses. Inset shows pyroglutamination ([M + 2H]2+; m/z 815.38) of the methionine oxidized peptide 73-85 ([M + 2H]2+; m/z 823.89). Panel C, ESI-QoTOF tandem MS spectra of the tryptic peptides ([M + 3H]3+; m/z 602.98) corresponding to residues 11-25 of calgranulin B. This confirmed the identification of P17 as calgranulin B. Superscript q, pyroglutamination; superscript O, oxidized methionine. Spectra were accumulated for 30-60 s; MALDI matrix was DHB; laser power, 50 µJ.

The triply charged ion at m/z 602.98 (M + 3H)3+ shown in Fig. 7B was subjected to a range of collision voltages (18-50 V), and the resultant data were summed (Fig. 7C). In this ESI-QoTOF tandem MS spectra the parent ion was m/z 602.97 (M + 3H)3+. Data base searching (PepSea) using the fragmentation data obtained from these experiments matched to the protein, calgranulin B. Fragment ions from the MS/MS spectrum (Fig. 7C) are labeled, and a partial b ion and y ion series is observed. As lower collision energy was required to fragment this multiply charged peptide, not as many immonium and internal ions, and amine and water losses, were observed, making the spectrum less complex than the CID spectrum of a singly charged peptide (Fig. 5B). However, it should be noted that, when running nano-ESI CID experiments, one also must be mindful of multiply charged fragment ions. For example, in the spectrum shown in Fig. 7C, both doubly and triply charged fragment ions are observed (m/z 790.38; y132+ and 564.96; y143+). The resolution of the QoTOF makes determination of peptide charge states straightforward (see insets). Reexamination of the MS spectra (Fig. 7, A and B) yielded other matching peptides confirming the protein identification with 61% sequence coverage. Again, several ions are observed that do not appear to correspond to the theoretical digest of calgranulin B. Some of these ions can be accounted for when the oxidation of methionine residues is taken into account. Furthermore, pyroglutamination is also observed. The inset of Fig. 7B shows tryptic peptide 73-85 with a methionine oxidized (m/z 823.89) and with pyroglutamination (m/z 815.38).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Data generated in these experiments using 2-DE provided qualitative comparison of the proteins present in EP, WS, and major glandular secretions, as well as definitive identification of selected proteins/peptides. It demonstrates that the combination of 2-DE coupled with MS techniques is a powerful tool to resolve individual components from complex protein/peptide mixtures and to characterize them with subpicomolar sensitivity.

Both 2-DE and mass spectrometry have unique characteristics and advantages for studies on complex mixtures such as EP and WS. The utilization of 2-DE allows for separation of not only different molecules with similar molecular masses, but also different modification patterns or isoforms of the same molecule. This resolution is exemplified by alpha -amylase, of which eight isoforms were detected with identical molecular mass ranging in pI from 5.9 to 7.2 (Fig. 3). Eight additional isoforms in the same pI range were found, each exhibiting a mobility change of 3 kDa in apparent molecular mass. Although this 3-kDa difference between glycosylated and non-glycosylated amylase was originally reported using a one-dimensional electrophoresis system (48, 49), the resolution into eight different isoforms was made possible through the use of this 2-DE approach.

The utilization of MS allows for unambiguous identification of proteins/peptides whether they already exist in the current data base or are hitherto unidentified molecules. This aspect is extremely important for studies of complex biological samples such as WS and EP. These samples comprise both known and novel proteins subject to modifications in the oral environment. The advantage of the technique employed is well demonstrated in the current study for the identification of calgranulin and cytokeratin family members, which represent novel EP constituents originating from non-salivary glandular sources. These discoveries were made feasible by our initial approach of obtaining tandem MS for selected tryptic fragments observed in the MS spectra to generate sequence-related product ions, which were then matched to theoretical data from proteins in a data base. Once a protein match with reasonable probability was obtained, the initial MS data were reevaluated to determine whether other tryptic peptides and known modifications from the proposed protein could be observed.

The combined utilization of 2-DE and MS provides complementary information on proteins/peptides. In MS experiments, we obtained a low coverage from some of the selected spots after trypsin digestion. This difficulty could be the result of resistance to proteolytic digestion of some proteins, incomplete recovery of digested peptides from the gel as a result of large size/hydrophobicity of some fragments, and/or low efficiency in peptide ionization. If only a minimal amount of data was acquired and no corroborating data (tandem MS or detection of a known modification) was obtained, protein identification was not reported. Whether an identified protein is intact or is a proteolytic fragment was determined by examining both MS and electrophoretic data. If an identified protein migrates to a similar pI and molecular mass as the reported intact form, it is likely that this protein is intact, even if not all peptides were observed in the MS spectrum. Using these criteria, we found evidence for the presence of intact statherin, amylase, albumin, cystatins SA-III, SA, and SN in WS, and intact histatin 1, statherin, and lysozyme in EP. The detection of intact cystatins, well known to be cysteine protease inhibitors, is consistent with previous studies where initial complete sequences were obtained on cystatin SN and SA purified from WS (50, 51). Contrary to expectation, these data reveal that other proteins can resist proteolysis and other modifications and a portion of such molecules can survive unaltered in the oral cavity. The two-dimensional electrophoretic positioning of amylase and albumin in our study were similar to those described in PS (52), suggesting that little, if any, modification occurred on these proteins after exposure to the oral environment. Although statherin and histatin 1 are known to be susceptible to bacterial degradation in the oral cavity, the mechanism by which a portion of these proteins remain intact in EP is unknown. Mechanistic possibilities for this finding include formation of covalent/non-covalent complexes with other proteins making enzyme cleavage sites inaccessible or conformational changes occurring after adsorption to enamel crystallites, rendering them resistant to proteolysis (53).

The present investigation showed that the electrophoretic patterns of proteins in glandular secretions were significantly different from those of WS and EP. These results suggested that proteins originating from non-glandular sources may contribute more significantly to WS and EP than previously recognized or that proteins may have undergone extensive proteolysis, cross-linking, and other modifications (54, 55). Some interesting contributors to EP are members of the cytokeratin family, cytokeratin 13 and 15 (56), pointing to oral epithelium as one of the sources of proteins deposited on the tooth surface. The cytokeratins identified in EP were distinct from those normally found in skin keratinocytes or hair (e.g. cytokeratin 9 or cuticular keratin), excluding the possibility that the proteins identified stem from sample contamination. Another novel component found in EP was calgranulin B, which has been previously identified in WS and was shown to be a component of gingival crevicular fluid (37). The calgranulin family contains a calcium-binding domain possibly involved in enamel deposition.

This study also revealed that the protein/peptide components of WS differed markedly from those of EP. This suggests that some EP constituents may derive directly from glandular secretions and other oral sources and that, contrary to expectations, the formation of EP is not totally dependent on protein modification occurring in WS. Comparison of WS and EP confirms the previously held notion that pellicle formation is dictated by a selective protein/peptide absorption process (5) and that the presence of phosphoproteins histatin 1 and statherin (2, 57) is consistent with the ionic interaction between proteins and enamel surfaces.

It is obvious that the identifications made in this study represent only a fraction of major pellicle components. Nevertheless, the current investigation showed the variety of novel as well as expected components in WS and EP, which are both extremely important to oral homeostasis. The use of proteomic technology overcame a number of limitations imposed by classic protein isolation and characterization methods. The results obtained open up a new avenue to directly characterizing EP, which should ultimately lead to an understanding of its three-dimensional structure and true functions.

    ACKNOWLEDGEMENTS

We thank ThermoBioanalysis Corp. and Applied Biosystems, Inc. for the loan of the Vision and QStarTM, respectively.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants DE07652 from NIDCR (to F. G. O.), DE05672 (F. G. O.), P41-RR10888 from National Center of Research Resources (to C. E. C.), and DE11691 from NIDCR (to R. F. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors made equal contributions to this work.

** To whom correspondence should be addressed: 700 Albany St., CABR Bldg., W-201, Boston, MA 02118. Tel.: 617-638-4942; Fax: 617-638-4924; E-mail: fropp@bu.edu.

Published, JBC Papers in Press, November 19, 2002, DOI 10.1074/jbc.M206333200

    ABBREVIATIONS

The abbreviations used are: WS, whole saliva; SMSL, submandibular/sublingual secretion; CID, collision-induced dissociation; ESI, electrospray ionization; QoTOF, quadrupole orthogonal time-of-flight; EP, enamel pellicle; MS, mass spectrometry; MALDI, matrix-assisted laser desorption/ionization; DHB, 2,5-dihydroxybenzoic acid; TOF, time-of-flight; 2-DE, two-dimensional electrophoresis; J, joule(s); PS, parotid secretion; PVDF, polyvinylidene difluoride; IPG, immobilized pH gradient; IEF, isoelectric focusing.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Oppenheim, F. G., Hay, D. I., and Franzblau, C. (1971) Biochemistry 10, 4233-4238[Medline] [Order article via Infotrieve]
2. Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., and Troxler, R. F. (1988) J. Biol. Chem. 263, 7472-7477[Abstract/Free Full Text]
3. Bennick, A., and Connell, G. E. (1971) Biochem. J. 123, 455-464[Medline] [Order article via Infotrieve]
4. Azen, E. A., and Oppenheim, F. G. (1973) Science 180, 1067-1069[Medline] [Order article via Infotrieve]
5. Hay, D. I. (1973) Arch. Oral Biol. 18, 1531-1541[Medline] [Order article via Infotrieve]
6. Hay, D. I., and Oppenheim, F. G. (1974) Arch. Oral Biol. 19, 627-632[CrossRef][Medline] [Order article via Infotrieve]
7. Eckersall, P. D., and Beeley, J. A. (1981) Biochem. Genet. 19, 1055-1062[Medline] [Order article via Infotrieve]
8. Anders, T., and Ole, F. (1985) Textbook of Cariology , 1st Ed. , Munksgaard, Copenhagen
9. Levine, M. J., Reddy, M. S., Tabak, L. A., Loomis, R. E., Bergey, E. J., Jones, P. C., Cohen, R. E., Stinson, M. W., and Al-Hashimi, I. (1987) J. Dent. Res. 66, 436-441[Abstract]
10. Kauffman, D. L., Bennick, A., Blum, M., and Keller, P. J. (1991) Biochemistry 30, 3351-3356[Medline] [Order article via Infotrieve]
11. Bobek, L. A., and Levine, M. J. (1992) Crit. Rev. Oral Biol. Med. 3, 307-332[Abstract]
12. Bobek, L. A., Tsai, H., Biesbrock, A. R., and Levine, M. J. (1993) J. Biol. Chem. 268, 20563-20569[Abstract/Free Full Text]
13. Lamkin, M. S., Migliari, D., Yao, Y., Troxler, R. F., and Oppenheim, F. G. (2001) J. Dent. Res. 80, 385-388[Abstract]
14. Hay. (1983) in Handbook of Experimental Aspects of Oral Biochemistry (Lazzari, E. P., ed) , pp. 44-67, CRC Press, Boca Raton, FL
15. Orstavik, D., and Kraus, F. W. (1974) Scand. J. Dent. Res. 82, 202-205[Medline] [Order article via Infotrieve]
16. Al-Hashimi, I., and Levine, M. J. (1989) Arch. Oral Biol. 34, 289-295[Medline] [Order article via Infotrieve]
17. Carlen, A., Borjesson, A. C., Nikdel, K., and Olsson, J. (1998) Caries Res. 32, 447-455[CrossRef][Medline] [Order article via Infotrieve]
18. Vacca Smith, A. M., and Bowen, W. H. (2000) Arch. Oral Biol. 45, 277-291[CrossRef][Medline] [Order article via Infotrieve]
19. Schupbach, P., Oppenheim, F. G., Lendenmann, U., Lamkin, M. S., Yao, Y., and Guggenheim, B. (2001) Eur. J. Oral Sci. 109, 60-68[Medline] [Order article via Infotrieve]
20. Jonsson, A. P. (2001) Cell. Mol. Life Sci. 58, 868-884[Medline] [Order article via Infotrieve]
21. Spengler, B., Karas, M., Bahr, U., and Hillenkamp, F. (1987) J. Phys. Chem. 91, 6502-6506
22. Karas, M., and Hillenkamp, F. (1988) Anal. Chem. 60, 2299-2301[Medline] [Order article via Infotrieve]
23. Chaurand, P., Luetzenkirchen, F., and Spengler, B. (1999) J. Am. Soc. Mass Spectrom. 10, 91-103[CrossRef][Medline] [Order article via Infotrieve]
24. Morris, H. R., Paxton, T., Dell, A., Langhorne, J., Berg, M., Bordoli, R. S., Hoyes, J., and Bateman, R. H. (1996) Rapid Commun. Mass Spectrom. 10, 889-896[CrossRef][Medline] [Order article via Infotrieve]
25. Shevchenko, A., Chernushevich, I., Ens, W., Standing, K. G., Thomson, B., Wilm, M., and Mann, M. (1997) Rapid Commun. Mass Spectrom. 11, 1015-1024[CrossRef][Medline] [Order article via Infotrieve]
26. Guilhaus, M., Selby, D., and Mlynski, V. (2000) Mass Spectrom. Rev. 19, 65-107[CrossRef][Medline] [Order article via Infotrieve]
27. Shevchenko, A., Loboda, A., Ens, W., and Standing, K. G. (2000) Anal. Chem. 72, 2132-2141[CrossRef][Medline] [Order article via Infotrieve]
28. Jungblut, P., Thiede, B., Zimny-Arndt, U., Muller, E. C., Scheler, C., Wittmann-Liebold, B., and Otto, A. (1996) Electrophoresis 17, 839-847[Medline] [Order article via Infotrieve]
29. Molloy, M. P., Herbert, B. R., Slade, M. B., Rabilloud, T., Nouwens, A. S., Williams, K. L., and Gooley, A. A. (2000) Eur. J. Biochem. 267, 2871-2881[Abstract/Free Full Text]
30. Chambers, G., Lawrie, L., Cash, P., and Murray, G. I. (2000) J. Pathol. 192, 280-288[CrossRef][Medline] [Order article via Infotrieve]
31. Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y., Liotta, L. A., Kohn, E. C., and Petricoin, E. F. R. (2002) Proteomics 2, 76-84[CrossRef][Medline] [Order article via Infotrieve]
32. Kuster, B., Krogh, T. N., Mortz, E., and Harvey, D. J. (2001) Proteomics 1, 350-361[CrossRef][Medline] [Order article via Infotrieve]
33. Steen, H., Kuster, B., Fernandez, M., Pandey, A., and Mann, M. (2002) J. Biol. Chem. 277, 1031-1039[Abstract/Free Full Text]
34. Yao, Y., Grogan, J., Zehnder, M., Lendenmann, U., Nam, B., Wu, Z., Costello, C. E., and Oppenheim, F. G. (2001) Arch. Oral Biol. 46, 293-303[CrossRef][Medline] [Order article via Infotrieve]
35. Marshall, T., and Williams, K. M. (1991) Electrophoresis 12, 461-471
36. Beeley, J. A., and Khoo, K. S. (1999) Electrophoresis 20, 1652-1660[CrossRef][Medline] [Order article via Infotrieve]
37. Kojima, T., Andersen, E., Sanchez, J. C., Wilkins, M. R., Hochstrasser, D. F., Pralong, W. F., and Cimasoni, G. (2000) J. Dent. Res. 79, 740-747[Abstract]
38. Carlson, A. J., and Crittenden, A. L. (1910) Am. J. Physiol. 26, 169-177[Free Full Text]
39. Wilkins, M. R., Pasquali, C., Appel, R. D., Ou, K., Golaz, O., Sanchez, J. C., Yan, J. X., Gooley, A. A., Hughes, G., Humphery-Smith, I., Williams, K. L., and Hochstrasser, D. F. (1996) Bio/Technology 14, 61-65[Medline] [Order article via Infotrieve]
40. Wilkins, M. R., and Williams, K. L. (1997) J. Theor. Biol. 186, 7-15[CrossRef][Medline] [Order article via Infotrieve]
41. Jensen, O. N., Wilm, M., Shevchenko, A., and Mann, M. (1999) Methods Mol. Biol. 112, 513-530[Medline] [Order article via Infotrieve]
42. Liu, B., Rayment, S., Oppenheim, F. G., and Troxler, R. F. (1999) Arch. Biochem. Biophys. 364, 286-293[CrossRef][Medline] [Order article via Infotrieve]
43. Jensen, O. N., Wilm, M., Shevchenko, A., and Mann, M. (1999) Methods Mol. Biol. 112, 571-588[Medline] [Order article via Infotrieve]
44. Papayannopoulos, I. A. (1995) Mass Spectrom. Rev. 14, 49-73
45. Roepstorff, P., and Fohlman, J. (1984) Biomed. Mass Spectrom. 11, 601[Medline] [Order article via Infotrieve]
46. Biemann, K. (1988) Biomed. Environ. Mass Spectrom. 16, 99-111[Medline] [Order article via Infotrieve]
47. Thiede, B., Lamer, S., Mattow, J., Siejak, F., Dimmler, C., Rudel, T., and Jungblut, P. (2000) Rapid Commun. Mass Spectrom. 14, 496-502[CrossRef][Medline] [Order article via Infotrieve]
48. Keller, P. J., Kauffman, D. L., Allan, B. J., and Williams, B. L. (1971) Biochemistry 10, 4867-4874[Medline] [Order article via Infotrieve]
49. Beeley, J. A., Sweeney, D., Lindsay, J. C., Buchanan, M. L., Sarna, L., and Khoo, K. S. (1991) Electrophoresis 12, 1032-1041[Medline] [Order article via Infotrieve]
50. Isemura, S., Saitoh, E., and Sanada, K. (1986) FEBS Lett. 198, 145-149[CrossRef][Medline] [Order article via Infotrieve]
51. Isemura, S., Saitoh, E., and Sanada, K. (1987) J. Biochem. (Tokyo) 102, 693-704[Abstract]
52. Beeley, J. A., Khoo, K. S., and Lamey, P. J. (1991) Electrophoresis 12, 493-499[Medline] [Order article via Infotrieve]
53. Gibbons, R. J. (1991) Infect. Immun. 59, 2948-2954[Medline] [Order article via Infotrieve]
54. Yao, Y., Lamkin, M. S., and Oppenheim, F. G. (1999) J. Dent. Res. 78, 1696-1703[Abstract]
55. Yao, Y., Lamkin, M. S., and Oppenheim, F. G. (2000) J. Dent. Res. 79, 930-938[Abstract]
56. Mischke, D., Wachter, E., Hochstrasser, K., Wild, A. G., and Schulz, P. (1989) Nucleic Acids Res. 17, 7984[Medline] [Order article via Infotrieve]
57. Schlesinger, D. H., and Hay, D. I. (1977) J. Biol. Chem. 252, 1689-1695[Abstract]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.